Mardirossian Facial Aesthetics Offers Top Forehead Contouring Procedures for Transgender Patients

Dr. Mardirossian’s plastic surgery clinic offers one of the most highly recommended forehead contouring procedures currently available.

JUPITER, FL, USA, February 28, 2018 /EINPresswire.com/ — Forehead contouring is a life-altering procedure which allows transgender patients undergoing a Facial Feminization Surgery (FFS) journey to become noticeably more female. This is important, as it not only takes transgender individuals one step closer to their end results, but also boosts the confidence of a woman trapped inside a man’s body.

Dr. Mardirossian’s plastic surgery clinic offers one of the most highly recommended forehead contouring procedures currently available. These services are offered through his south Florida office, and are raved about by his previous and current clients. But why is forehead contouring such a vital part of the FFS journey?

The forehead is one of the features defining both men and women. A man typically has a much heavier brow, which casts a shadow over his eyes and the surrounding facial region. This makes the eyes appear smaller. Women, on the other hand, tend to have a softer oval-shaped contour to their brows which is lighter and more delicate. This allows the light to flow into the eyes and surrounding region to allow an appearance of being brighter and larger.

How does Dr. Mardirossian and his highly-trained, supportive staff conduct this procedure for his transgender patients?
It begins with a small incision just behind the hairline which allows him access to the frontal bone (i.e. the bone which shapes your forehead). The placement of the incision allows for hair to grow over it, thus hiding it away where others cannot see. Then the bone is shaved down to alter its shape. Sometimes this is enough to make the forehead area appear more feminine, particularly if the patient has a heavy brow line. Sometimes a patient’s brow is not thick enough, however. When this occurs, the frontal sinus wall located just behind the brow is removed and reshaped towards the desired results. It is then replaced behind the brow.

The recovery process varies from person to person. When you awake from forehead contouring surgery there is a soft dressing and stitches along the forehead. This is removed after seven days’ time. Swelling and discomfort are normal for the first few days, and patients should remember to take it easy to allow for the body to heal. Most patients can return to work and their normal routines after one to two weeks, although some may require additional time. Numbness in the forehead region off and on for up to three months is also very normal.

Complications are incredibly rare, thanks to Dr. Mardirossian’s skill and care during the procedure. Like all surgeries, however, they do have the potential of arising. Rare but serious complications include: infection, excessive swelling or bruising, nerve injury, and permanent forehead numbness.

Dr. Vartan Mardirossian
Mardirossian Facial Aesthetics
561-624-0900
email us here


Source: EIN Presswire

Shema Kolainu Hosts Workshop Featuring Dalia Zwick, PT, PhD

Dalia Zwick Presents Therapeutic Positioning Workshop

NEW YORK, NEW YORK, UNITED STATES, February 28, 2018 /EINPresswire.com/ — NEW YORK, NY–(EIN Presswire – February 28, 2018) – Shema Kolainu – Hear Our Voices hosted a free autism workshop at Touro College in New York City on Tuesday, February 27th. Acclaimed Physical Therapy Specialist, Dalia Zwick, PhD, presented a therapeutic approach to the posture and gait issues in individuals with ASD, Autism Spectrum Disorder. The room was filled with Physical Therapists, parents of autistic children, Special Education teachers, Early Intervention Specialists and other healthcare professionals.

This workshop focused on proper body alignment and physical positioning for children with Autism but was also very informative on general posture imbalances and the importance of correcting them. Most of the time, we aren’t aware of our slouching but over time it has an adverse affect. She states, “by the age of five, if something is being repeated, the body remembers it and becomes very difficult to correct”.

Her unique specialty was derived from her yoga practice as well as taking on an interest in sketching and animation to better understand correct body posturing whether it’s sitting, standing, walking, or even sleeping. The group participated in a few exercises to experience imbalanced strain, realignment and proper body positioning.

Dr. Zwick developed using parallel bars in her practice to help individuals feel how to stand correctly and comfortably aligned. Another interesting point she made was that kids with ASD don’t ever get a chance to relax if their body isn’t supported and comfortable. Relaxation is extremely important for overall health and particularly necessary in order for children to be alert and engaged in their learning environment.

For more information about Dalia Zwick and therapeutic positioning visit www.therapeutic-positioning.com.

Shema Kolainu – Hear our Voices, is a school and center for autism, an educational organization dedicated to the support and education of individuals with Autism Spectrum Disorders (ASD) and a leader in the field of special needs education. The workshop series is a great opportunity to gain knowledge from some of the best resources in the field of Autism. These Autism workshops are made possible by the NYC Council Autism Initiative Funding and are held are held throughout the year. The next workshop will be held on March 27th, features Sara Goldstein, M.S. Ed., CCC-SLP, TSSLD, presenting “AAC – Augmentative and alternative Communication.”

About Shema Kolainu
Shema Kolainu is one of the sponsors of the ICare4Autism International Conference: Genes, Technology, and Clinical Care, to be held in November.

For more information or to sign up for a free workshop, please visit www.shemakolainu.org or contact info@skhov.org.

Shema Kolainu – Hear Our Voices
4302 New Utrecht Avenue
Brooklyn, NY 11219
718-686-9600

Jamie Friederick
Shema Kolainu – Hear Our Voices
718-686-9600
email us here


Source: EIN Presswire

Regenerative Medicine Plus Announces Stem Cell Therapy and Other Regenerative Solutions Using Your Own Body's Cells

Regenerative Medicine Plus, an innovative clinic has added stem cell therapy injections to its menu of non-surgical methods to treat knee and shoulder pain.

We offer a system that researchers have developed and has been approved for use by the FDA under their most recent guidance. It overcomes the limitations of traditional bone marrow harvesting.”

— Dr. David Feld

JUPITER, FL, USA, February 28, 2018 /EINPresswire.com/ — Using a safe FDA approved procedure which collects your body’s stem cells and injects them directly into the injured or degenerated joints to reduce pain and restore tissue. It is now possible to harness the healing power of your own stem cells. This is a regenerative non-surgical option in an industry that has relied on degenerative and temporary options.

Dr. David Feld, the clinics' medical director, states “We are offering a system that researchers have recently developed and has been approved for use by the FDA under their most recent guidance. This system overcomes the downside limitations of traditional bone marrow harvesting.” This innovation gives the patient an injection that is so rich in key stem and progenitor cells that the aspirate no longer requires manipulation and use of a centrifuge. Dr. Feld adds “Our patients are looking for regeneration and restoration, most have tried cortisone or other shots and have been told they are candidates for joint replacement but do not want the surgery or the long rehab that follows surgery” This is a wonderful technology that offers an alternative to surgery and medication for pain free living.

About Regenerative Medicine Plus

Formerly Healthier U Jupiter, Regenerative Medicine Plus is a health and wellness practice; offering customized therapies and treatment plans based on the individual’s injuries and symptoms. We have seen success when treating tennis elbow, golfers elbow, peripheral neuropathy, plantar fasciitis, rotator cuff injuries, chronic shoulder pain, knee pain and chronic foot pain. Regenerative Medicine Plus specializes in regenerative therapies such as bone marrow derived stem cell and PRP (platelet rich plasma) injections, to put a halt to the degenerative process of joints. PRP is derived from the components of the patient’s blood, called platelets, that triggers the body’s natural healing process. This autologous treatment has been used for many years to treat the injuries of professional athletes in the NFL, NBA, and PGA.

Regenerative Medicine Plus is located at 240 West Indiantown rd. Suite 107. The web address is http://www.regenmedplus.com. The clinic can be contacted at (561) 250-STEM (7836) or info@regenmedplus.com. Regenerative Medicine Plus is focused on relieving pain from knee and shoulder joints. They offer a multi-therapeutic approach to pain solutions that include:
· Stem Cells, using your own stem cells
· PRP – Protein Rich Plasma Injections
· Trigenics joint therapy
· Whole Body Vibration training
· Strength and Balance training
· Peripheral Neuropathy solutions

Lauren Matthews
Regenerative Medicine Plus
561-250-STEM (7836)
email us here


Source: EIN Presswire

Intermountain Healthcare Opens New Hospital — Without a Building or Walls

The virtual hospital is one of the largest of its type in U.S., will make services available to underserved areas

SALT LAKE CITY, UTAH, USA, February 28, 2018 /EINPresswire.com/ — Intermountain Healthcare has launched one of the nation’s largest virtual hospital services – called Intermountain Connect Care Pro – bringing together 35 telehealth programs and more than 500 caregivers to enable patients to receive the medical care they need, regardless of where they are.

Connect Care Pro provides basic medical care as well as advanced services, such as stroke evaluation, mental health counseling, intensive care, and newborn critical care. While it doesn’t replace the need for on-site caregivers, it supplements existing staff and provides specialized services in rural communities where those types of medical care usually aren’t readily available.

Because the healthcare services are online and digital, Connect Care Pro isn’t located in a specific building, but provides much of the same care that you’d find in a large, medically advanced hospital. This clinically integrated, digitally-enabled approach not only improves the quality of care in the communities served, but saves patients and clinicians time and money.

For example, an infant at a southern Utah hospital was being supported via Connect Care Pro services and received a critical care consultation that allowed the sick baby to stay in that facility instead of being transferred to a newborn intensive care unit in Salt Lake City. This single avoided transfer would have cost over $18,000 dollars. The parents of this baby were able to remain in their community, surrounded by their support system, instead of traveling what would have amounted to 400 miles and seven hours round-trip every time they wanted to see their baby. Using this technology to reduce the need for transfers of ill newborns to other hospitals, Intermountain lowered the cost of care for patients by more than $2.1 million over several years.

All Intermountain Healthcare hospitals including 10 of Intermountain’s rural hospitals use the offerings of the virtual hospital to supplement or add to their existing services, and nine hospitals outside the Intermountain Healthcare system have already signed up to provide high-level care and keep patients closer to home whenever possible.

One such hospital is Kane County Hospital, an independent rural facility located in Kanab, Utah. “Our partnership with Intermountain Connect Care Pro has had a huge positive impact on our community,” said Charlene Kelly RN, BSN, chief nursing officer at the hospital. “Kanab has had one of the highest suicide rates in the state, not including patients that come to us from our border town in Arizona, and we don’t have a crisis worker here. Trying to place a patient who has not had a crisis evaluation was next to impossible. With crisis care from Intermountain Healthcare, patients receive that crisis evaluation in less than an hour, and if the crisis worker recommends inpatient treatment they assist in placing the patient. Our providers just love having this service available.”

Intermountain Connect Care Pro also plans to extend these services in the community where they can easily be accessed in underserved areas. Discussions are underway to put patient kiosks or access devices in locations such as homeless shelters, schools, community centers, and perhaps jails, to make getting needed care more accessible.

Intermountain Healthcare is a Utah-based, not-for-profit system of 22 hospitals, 180 clinics, a Medical Group with some 1,500 employed physicians, a health plans division called SelectHealth, and other health services. Helping people live the healthiest lives possible, Intermountain is widely recognized as a leader in transforming healthcare through high quality and sustainable costs. For more information about Intermountain, visit intermountainhealthcare.org.

Daron Cowley
Intermountain Healthcare
801-442-2834
email us here


Source: EIN Presswire

Exploring Ibogaine Treatment From the Paradise Island Setting of the Avante Institute

iboga plant

NASSAU, NASSAU, BAHAMAS, February 28, 2018 /EINPresswire.com/ — Ibogaine has long been understood to provide therapeutic effects, most notably in the elimination of addiction to opiates, alcohol, and other drugs.

Ibogaine occurs naturally in a group of flowering plants commonly known as the dogbane family. The group includes all manner of plants, from shrubs and trees to herbs, succulents, and vines.

Even before the advent of modern medicine, ibogaine had been recognized for its medicinal properties. Initially documented by French and Belgian explorers to Africa in the 19th century, botanists soon took an interest, first describing the 'Tabernanthe iboga' plant in 1889.

Based in the beautiful Bahamas, The Avante Institute harnesses the natural power of ibogaine to treat addiction to drugs and alcohol.

Home to the world's sixth-longest barrier reef, the coral-based archipelago of the Bahamas is known for its breathtaking scenery, varied wildlife, lush palms, rare orchids, and tropical climate.

Of its ibogaine treatments, the New Providence Island-based institute says, "The Avante Institute offers treatment packages for all manner of substance detoxification including alcohol, opioid medications, heroin, cocaine, methadone and more."

Part of what's being called the "holistic plant movement," The Avante Institute's detox treatment facility is fast becoming one of the most well-respected providers of holistic therapy in the battle against addiction to drugs and alcohol.

A representative for The Avante Institute explains, saying, "Powerful yet gentle holistic plant medicines are the genuine article. They heal people, and they save lives."

They continue, "This is what we've been searching for, and what's desperately needed to attack the modern-day addiction epidemic head-on. Our plant medicine treatments work like no other medicines in the world."

Treatment with ibogaine works by resetting specific transmitters in the brain, while simultaneously rebalancing a number of essential chemicals in the body.

Ibogaine is unique, in that it allows those undergoing treatment to bypass the withdrawal symptoms often associated with drug or alcohol detox, known as post-acute withdrawal symptoms. None of these symptoms—which can include nausea, cramping, tremors, headaches, irritability, chills, and sweats—are typically witnessed with the institute's carefully administered ibogaine treatment regime.

"The advantages which these treatments offer our clients over traditional detox are immeasurable," says the institute.

The Avante Institute has enjoyed excellent rates of success through its ibogaine treatments, with levels of long-term sobriety being "exceptional" according to the Caribbean holistic retreat's records.

Located on two acres of pristine white sand beachfront, the institute boasts a team of compassionate and highly-experienced professionals and addiction specialists. Through intensive entheogenic medicinal treatments, the site enjoys levels of efficacy in drug rehabilitation not found or available in western medicine today.

"We confidently proclaim our detoxification therapies to be among the very finest in the world," says the institute.

The Avante Institute offers a number of withdrawal-free ibogaine treatments from its oceanfront Nassau location, ranging in length from 5-10 days, with an extended care program also available.

For more information about the institute, and about ibogaine treatment, visit https://avanteinstitute.com/.

Eric Ash
Web Presence, LLC
941-266-8620
email us here


Source: EIN Presswire

Must-attend conference gather a global PFS sector audience to discuss and accelerate pre-filled syringe development

Pre-Filled Syringes West Coast Conference

Pre-Filled Syringes West Coast Conference

SAN DIEGO, USA , February 28, 2018 /EINPresswire.com/ — Pre-Filled Syringes West Coast
Conference: June 4 – 5th, 2018
Interactive Workshops: June 6th, 2018
San Diego, USA
http://www.prefilled-syringes-westcoast.com/ein

The agenda of the SMi’s 3rd annual Pre-Filled Syringes West Coast conference will provide a comprehensive overview for market participants to share and benchmark against colleagues' best practice, to ensure optimal development in all aspects of pre-filled syringe design and production.

Pre-Filled Syringes West Coast series is in its’ 3rd year and is now becoming an established and prominent market-leader within this field in the US market. This must-attend conference will gather a global sector audience to discuss and accelerate pre-filled syringe development in various sub-fields.

Visit the website for further details http://www.prefilled-syringes-westcoast.com/ein

NEW FOR 2018:

– Explore and engage with the evolving industry of pharmaceutical manufacturing related to PFS, from cross-site development to navigating injection technologies through the design life-cycle
– Assess quality control systems and risk-based control strategies for drug delivery devices
– Consider the importance of Human Factors Engineering, from Rate of Return to the Design History File
– Highlights on emerging trends of technologies and studies to assist device and drug formulation developers
– Perceive the regulatory expectations from cross-border perspectives in the EU and US and what can we do to face these challenges

WHO WILL YOU HEAR FROM

• Darin Oppenheimer, Executive Director, Drug Device Center of Excellence, Merck
• Ron Forster, Director, Process Development, Amgen
• Michael Song, Senior Manager, Drug Delivery and Device Development, MedImmune
• Paul Upham, Senior Principal, Smart Device Technology Center, Genentech
• Arnaz Malhi, Associate Director, Device Development Lead, Shire
• Michael Regn, Director, Packaging Design & Development, Allergan
• Ed Israelski, Consultant – Technical Advisor on Human Factors, Retired Director Human Factors, AbbVie
• Maria Toler, Quality Portfolio Support and Innovation-Drug Delivery Systems and Medical Devices, Pfizer
• David Post, Director, Science and Technology, AbbVie
• Tina Rees, Associate Director, Human Factors, Ferring
• Torsten Vilkner, Senior Associate Director, Manufacturing Operations, Boehringer Ingelheim

Full agenda, list of speakers and booking form at http://www.prefilled-syringes-westcoast.com/ein

Twitter – @SMIpharm & #smipfsusa
LinkedIn – SMi Pharma

CONTACT:
+44 (0)20 7827 6000
events@smi-online.co.uk
http://www.prefilled-syringes-westcoast.com/ein

——————————————————————————————-
Pre-Filled Syringes West Coast | Conference: June 4 – 5th, 2018 | Interactive Workshops: June 6th, 2018
http://www.prefilled-syringes-westcoast.com/ein
——————————————————————————————-

Lyudmyla Durneva
SMi Group
email us here
+44 (0)20 7827 6000


Source: EIN Presswire

Six leading pharma firms to participate at Pharmaceutical Microbiology event in San Diego

Pharmaceutical Microbiology West Coast

LONDON, UNITED KINGDOM, February 28, 2018 /EINPresswire.com/ — SMi’s 2nd Annual Pharmaceutical Microbiology West Coast Conference will be taking place in San Diego, USA on the 7th – 8th June 2018. The conference will be focusing on the various issues the pharmaceutical industry is facing, including aseptic practice and contamination prevention, mycoplasma testing, water monitoring, biofilms and much more. The launch event in 2017 saw over 60 industry professionals attend, as well as over 5 hours of dedicated networking.

The success of last year’s event saw the sponsors Biomerieux and Charles River returning for this year’s annual event. The Pharmaceutical Microbiology West Coast Conference 2018 is also sponsored by Associates of Cape Cod Inc, Fujifilm Wako Chemicals U.S.A Corporation, MilliporeSigma and Roche.

2018 Sponsors:

• Biomerieux: Microbiologists committed to keeping your lab running smoothly and ensuring that your products are safe.
• Charles River: Helping customers bring products to the market safely and efficiently with revolutionary technologies and exceptional services, changing the way we conduct microbial quality control.
• Associates of Cape Cod, Inc: Endotoxin experts specialising in chromogenic and turbidimetric reagent technologies.
• Fujifilm Wako Chemicals U.S.A Corporation: World-renowned supplier of high purity chemicals with over 30 years of research and development dedicated to providing innovative endotoxin-specific reagents and consumables for “every user and every method”.
• MilliporeSigma: Solving the toughest problems in life sciences by collaborating with the global scientific community, providing scientists and engineers with best-in-class lab materials, technologies and services.
• Roche: Developing medicines and diagnostics that help patients live longer, better lives.

Speaking to Senior Manager Lisa Komski from our sponsor Fujifilm Wako Chemicals U.S.A Corporation, she stated that she expects the conference to provide a ‘great opportunity to connect with key members in the fields of microbiology, quality control, research and pharmaceutical manufacturing’ as well as the opportunity to meet and network with ‘QC Managers, Microbiologists, dialysis technicians, pharmaceutical manufacturing personnel and veterinary lab technicians ‘. Fujifilm Wako Chemicals U.S.A Corporation will be exhibiting their products at the event, attend the event and visit them to learn how Fujifilm Wako Chemicals U.S.A Corporation can best support your quality testing needs.

For the full agenda and speaker line-up visit the website to download the brochure here – www.pharma-microbiology-usa.com/ein

Interested in sponsoring and/or exhibiting at this event?
Contact Alia Malick, Director, on +44 (0) 20 827 6168 or email amalick@smi-online.co.uk

If you would like to attend as a delegate at this event take full advantage of the early bird discount at US$200 off the full conference price for the 2-day conference (standard price is at US$1999).

Offer ends on March 29th. Register online at www.pharma-microbiology-usa.com/ein or call Keiron on +44 (0) 207 827 6744.
________________________________________

For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6162 or ssapal@smi-online.co.uk

Pharmaceutical Microbiology USA
7 – 8 June 2018
Crown Plaza San Diego, CA, USA

www.pharma-microbiology-usa.com/ein

Contact e-mail: ssapal@smi-online.co.uk
Contact tel: +44 (0) 207 827 6162
#pharmamicrousa

—- END —-
About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Simi Sapal
SMi Group
email us here
+44 (0) 207 827 6162


Source: EIN Presswire

Global Oats Market 2018 Key Players, Supply, Demand, Growth, Application, Analysis and Forecast to 2025

PUNE, INDIA, February 28, 2018 /EINPresswire.com/ — Oats Market 2018

Wiseguyreports.Com adds “Oats Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025” To Its Research Database.

Report Details:

This report provides in depth study of “Oats Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Oats Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Global Oats market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer;

The top key players including ;
The Quaker Oats Company
Grain Millers
Blue Lake Milling
Avena Food
Richardson International
Morning Foods
Guilin Simieon Food Group
Viz Branz
Ernsts Foods (Shenzhen)
AHDB Cereals & Oilseeds
Jordans, Dorset & Ryvita 

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2955942-global-oats-market-research-report-2018

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Oats in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India 

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Steel-Cut Oats
Rolled Oats
Instant Oats 

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Animal Feed
Consumer Food
Cosmetics
Others

This report provides valuable information for companies like manufacturers, suppliers, distributors, traders, customers, investors and individuals who have interests in this industry.

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@ https://www.wiseguyreports.com/reports/2955942-global-oats-market-research-report-2018

Major Key Points in Table of Content:

Global Oats Market Research Report 2018
1 Oats Market Overview
1.1 Product Overview and Scope of Oats
1.2 Oats Segment by Type (Product Category)
1.2.1 Global Oats Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Oats Production Market Share by Type (Product Category) in 2017
1.2.3 Steel-Cut Oats
1.2.4 Rolled Oats
1.2.5 Instant Oats
1.3 Global Oats Segment by Application
1.3.1 Oats Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Animal Feed
1.3.3 Consumer Food
1.3.4 Cosmetics
1.3.5 Others
1.4 Global Oats Market by Region (2013-2025)
1.4.1 Global Oats Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Oats (2013-2025)
1.5.1 Global Oats Revenue Status and Outlook (2013-2025)
1.5.2 Global Oats Capacity, Production Status and Outlook (2013-2025)

….

7 Global Oats Manufacturers Profiles/Analysis
7.1 The Quaker Oats Company
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Oats Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 The Quaker Oats Company Oats Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Grain Millers
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Oats Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Grain Millers Oats Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Blue Lake Milling
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Oats Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Blue Lake Milling Oats Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Avena Food
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Oats Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Avena Food Oats Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Richardson International
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Oats Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Richardson International Oats Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.5.4 Main Business/Business Overview
7.6 Morning Foods
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Oats Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Morning Foods Oats Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Guilin Simieon Food Group
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Oats Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Guilin Simieon Food Group Oats Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Viz Branz
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Oats Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Viz Branz Oats Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 Ernsts Foods (Shenzhen)
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Oats Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Ernsts Foods (Shenzhen) Oats Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.10 AHDB Cereals & Oilseeds
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Oats Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 AHDB Cereals & Oilseeds Oats Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.10.4 Main Business/Business Overview
7.11 Jordans, Dorset & Ryvita

Continued….

 

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Body Creams & Body Lotions Market 2018 Consumption Volume, Value, Sale Price,Import & Export Report Forecast 2025

PUNE, INDIA, February 28, 2018 /EINPresswire.com/ — Body Creams & Body Lotions Market 2018

Wiseguyreports.Com adds “Body Creams & Body Lotions Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025” To Its Research Database.

Report Details:

This report provides in depth study of “Body Creams & Body Lotions Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Body Creams & Body Lotions Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Global Body Creams & Body Lotions market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer;

The top key players including ;
L'OCCITANE 
everyBody Labo 
CLARINS 
Johnson & Johnson 
Unilever 
The Body Shop 
Alpha Hydrox 
Beiersdorf 
Soap & Glory 
Yumeijing 
NatureLab 
herbacin 
Galderma 
Pechoin 

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2949312-global-body-creams-body-lotions-market-research-report-2018

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Body Creams & Body Lotions in these regions, from 2013 to 2025 (forecast), covering 
North America 
Europe 
China 
Japan 
Southeast Asia 
India 

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into 
Moisturising 
Protective 
Repair 
Others 

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including 
Adult 
Children 
Baby

This report provides valuable information for companies like manufacturers, suppliers, distributors, traders, customers, investors and individuals who have interests in this industry.

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@ https://www.wiseguyreports.com/reports/2949312-global-body-creams-body-lotions-market-research-report-2018

Major Key Points in Table of Content:

Global Body Creams & Body Lotions Market Research Report 2018 
1 Body Creams & Body Lotions Market Overview 
1.1 Product Overview and Scope of Body Creams & Body Lotions 
1.2 Body Creams & Body Lotions Segment by Type (Product Category) 
1.2.1 Global Body Creams & Body Lotions Production and CAGR (%) Comparison by Type (Product Category)(2013-2025) 
1.2.2 Global Body Creams & Body Lotions Production Market Share by Type (Product Category) in 2017 
1.2.3 Moisturising 
1.2.4 Protective 
1.2.5 Repair 
1.2.6 Others 
1.3 Global Body Creams & Body Lotions Segment by Application 
1.3.1 Body Creams & Body Lotions Consumption (Sales) Comparison by Application (2013-2025) 
1.3.2 Adult 
1.3.3 Children 
1.3.4 Baby 
1.4 Global Body Creams & Body Lotions Market by Region (2013-2025) 
1.4.1 Global Body Creams & Body Lotions Market Size (Value) and CAGR (%) Comparison by Region (2013-2025) 
1.4.2 North America Status and Prospect (2013-2025) 
1.4.3 Europe Status and Prospect (2013-2025) 
1.4.4 China Status and Prospect (2013-2025) 
1.4.5 Japan Status and Prospect (2013-2025) 
1.4.6 Southeast Asia Status and Prospect (2013-2025) 
1.4.7 India Status and Prospect (2013-2025) 
1.5 Global Market Size (Value) of Body Creams & Body Lotions (2013-2025) 
1.5.1 Global Body Creams & Body Lotions Revenue Status and Outlook (2013-2025) 
1.5.2 Global Body Creams & Body Lotions Capacity, Production Status and Outlook (2013-2025)

….

7 Global Body Creams & Body Lotions Manufacturers Profiles/Analysis 
7.1 L'OCCITANE 
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.1.2 Body Creams & Body Lotions Product Category, Application and Specification 
7.1.2.1 Product A 
7.1.2.2 Product B 
7.1.3 L'OCCITANE Body Creams & Body Lotions Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.1.4 Main Business/Business Overview 
7.2 everyBody Labo 
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.2.2 Body Creams & Body Lotions Product Category, Application and Specification 
7.2.2.1 Product A 
7.2.2.2 Product B 
7.2.3 everyBody Labo Body Creams & Body Lotions Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.2.4 Main Business/Business Overview 
7.3 CLARINS 
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.3.2 Body Creams & Body Lotions Product Category, Application and Specification 
7.3.2.1 Product A 
7.3.2.2 Product B 
7.3.3 CLARINS Body Creams & Body Lotions Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.3.4 Main Business/Business Overview 
7.4 Johnson & Johnson 
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.4.2 Body Creams & Body Lotions Product Category, Application and Specification 
7.4.2.1 Product A 
7.4.2.2 Product B 
7.4.3 Johnson & Johnson Body Creams & Body Lotions Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.4.4 Main Business/Business Overview 
7.5 Unilever 
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.5.2 Body Creams & Body Lotions Product Category, Application and Specification 
7.5.2.1 Product A 
7.5.2.2 Product B 
7.5.3 Unilever Body Creams & Body Lotions Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.5.4 Main Business/Business Overview 
7.6 The Body Shop 
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.6.2 Body Creams & Body Lotions Product Category, Application and Specification 
7.6.2.1 Product A 
7.6.2.2 Product B 
7.6.3 The Body Shop Body Creams & Body Lotions Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.6.4 Main Business/Business Overview 
7.7 Alpha Hydrox 
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.7.2 Body Creams & Body Lotions Product Category, Application and Specification 
7.7.2.1 Product A 
7.7.2.2 Product B 
7.7.3 Alpha Hydrox Body Creams & Body Lotions Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.7.4 Main Business/Business Overview 
7.8 Beiersdorf 
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.8.2 Body Creams & Body Lotions Product Category, Application and Specification 
7.8.2.1 Product A 
7.8.2.2 Product B 
7.8.3 Beiersdorf Body Creams & Body Lotions Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.8.4 Main Business/Business Overview 
7.9 Soap & Glory 
7.10 Yumeijing  

Continued….

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Maryrose Petrizzo to be Featured on CUTV News Radio

WILMINGTON, DELAWARE, UNITED STATES, February 28, 2018 /EINPresswire.com/ — Maryrose is a seasoned quality assurance professional and owner of Clinical Quality Assured a consulting business that provides good clinical practice expertise for the conduct of clinical trials within the pharmaceutical, biopharmaceutical, and medical device industries since 2015.

“Its focus is basically the subject safety and data integrity of experimental drugs investigated in humans,” says Maryrose. “There are numerous regulations and as an expert in these regulations it should be noted there is not just one method to comply which gives a lot of flexibility to companies and I assist them in recognizing the balance between complying with the spirit of the regulation versus the letter of the law, while maintaining business needs.”

Working as a chemist, Maryrose started her career in the environmental compliance area before transitioning into pharmaceutical compliance and when she began auditing clinical trials she thoroughly enjoyed the challenge and how every new drug and study is different and distinctive.

“It takes a minimum of ten years to get a new drug approved and there’s millions of dollars invested to conduct these studies,” says Maryrose. “However, its critical to conduct these clinical trials since we urgently need pharmaceuticals or devices to aid us with the maintenance of our health.”

Regulations have evolved tremendously in the 22 years Maryrose have been in the pharmaceutical industry with an ever increasing emphasis on safety.

“Don’t be afraid of clinical trials because of the exemplary way they are designed and regulated,” says Maryrose. “Clinical trials is one of the best tools for managing diseases because, you are monitored so very closely. and the quality of the health care and safety of the patients is generally exceptional, so I highly recommend anyone to get involved in a clinical trial so we can continue producing high quality drugs.”

Aside from her well regarded work conducting clinical trials Maryrose is also an ordained Roman Catholic Woman Priest.

“There are approximately three hundred ordained women throughout the world and although we are not recognized by the Vatican because they don’t believe women should be ordained,” explains Mary Rose. “But we have been called to serve by the community and unlike male priest we have no hierarchy when we get ordained we don’t take vows of obedience to the bishop like the men do. Consequently our communities are all equal with the priest being just one member of the community mainly present for spiritual leadership and everyone in the parish having a responsibility and accountability within the community.”

Maryrose was innately drawn to ministry since she was a teenager becoming active in the church and felt so thoroughly fulfilled from her work she later obtained her Masters in Pastoral care and counseling that was completely life changing.

“I must support myself, so I am a working priest unlike the institutional church, the male priests are given salary, health care benefits, and homes to live in but I pay all that myself,” says Maryrose. “I am so fortunate and extremely blessed to have a career that that affords me the opportunity to serve others in ministry.”

CUTV news will feature Maryrose Petrizzo in an interview with Jim Masters March 2nd at 10 a.m. EST.

Listen to the show on BlogTalkRadio.

If you have any questions for our guest please call (347) 996-3389.

Author: Beatrice Maria Centeno

Lou Ceparano
CUTV News
(631) 850-3314
email us here


Source: EIN Presswire